APA (7th ed.) Citation

Lu, C., Cheng, D., Xie, Y., Shang, M., Chen, R., Zhu, Y., . . . Zhou, H. (2025). Effect of CYP3A4 inhibitor and induction on the pharmacokinetics and safety of FHND9041, a novel EGFR T790M inhibitor, in healthy Chinese. BMC pharmacology & toxicology, 26(1), 97-14. https://doi.org/10.1186/s40360-025-00930-2

Chicago Style (17th ed.) Citation

Lu, Chang, Dongmei Cheng, Yunqiu Xie, Minghong Shang, Rongzhen Chen, Yongqiang Zhu, Jian Gong, and Huan Zhou. "Effect of CYP3A4 Inhibitor and Induction on the Pharmacokinetics and Safety of FHND9041, a Novel EGFR T790M Inhibitor, in Healthy Chinese." BMC Pharmacology & Toxicology 26, no. 1 (2025): 97-14. https://doi.org/10.1186/s40360-025-00930-2.

MLA (9th ed.) Citation

Lu, Chang, et al. "Effect of CYP3A4 Inhibitor and Induction on the Pharmacokinetics and Safety of FHND9041, a Novel EGFR T790M Inhibitor, in Healthy Chinese." BMC Pharmacology & Toxicology, vol. 26, no. 1, 2025, pp. 97-14, https://doi.org/10.1186/s40360-025-00930-2.